InfuSystem (INFU) Short Interest Ratio & Short Volume

Short interest is the volume of InfuSystem shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 215,400 shares of INFU short. 1.15% of InfuSystem's shares are currently sold short. Learn More on InfuSystem's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. INFU shares currently have a short interest ratio of 5.0. Learn More on InfuSystem's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.15% of InfuSystem's floating shares are currently sold short.

InfuSystem saw a drop in short interest in April. As of April 15th, there was short interest totaling 215,400 shares, a drop of 7.8% from the previous total of 233,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

InfuSystem currently has issued a total of 21,260,000 shares. Some of InfuSystem's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. InfuSystem currently has a public float of 18,660,000 shares.

1.15% of InfuSystem's shares are currently sold short. Here is how the short interest of companies in the industry of "surgical & medical instruments" compare to InfuSystem: Orchestra BioMed Holdings, Inc. (3.75%), Quipt Home Medical Corp. (1.42%), ClearPoint Neuro, Inc. (4.54%), Alpha Tau Medical Ltd. (0.08%), Profound Medical Corp. (1.28%), Delcath Systems, Inc. (3.23%), TELA Bio, Inc. (3.76%), Accuray Incorporated (5.49%), AVITA Medical, Inc. (4.97%), Neuronetics, Inc. (0.19%),

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks.

Short selling INFU is an investing strategy that aims to generate trading profit from InfuSystem as its price is falling. INFU shares are trading up $0.21 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for InfuSystem occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of INFU, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INFU, twice per month. The most recent reporting period available is April, 15 2024.